Please assess the completion status of the following clinical trial:

Trial Title: Relieving Acute Pain (RAP) Study: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-65~* Admission to The Shock Trauma Center within 72 hrs~* Any trauma requiring inpatient opioid medication~* Plan by primary service to follow the Shock Trauma Guidelines for Acute Pain in Orthopedic Injury~* Predicted length of stay greater than or equal to 2 days~Exclusion Criteria:~* Non English speaking~* Spine cord injury~* Severe Traumatic brain injury (based on a Glascow Coma Scale of 8 or less)~* Patient-controlled analgesia~* Admission Creatinine \> 1.4~* History of chronic kidney disease~* Heroin use in the 3 months prior to admission (patient self-report)~* Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, mania, autism) and /or psychiatric condition leading to treatment and/or hospitalization within the last 1 year.~* Positive toxicology screen for methadone not prescribed during current hospitalization~* Pregnancy or breast feeding~* Contraindication to NSAIDs, including high risk of bleeding or known severe coronary artery disease~* Injuries deemed non survival.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Full Dose (FD) (Type: ACTIVE_COMPARATOR): Participants in the FD arm will receive NSAIDs and Oxycodone (5mg).dosed in accordance with the Guidelines for Use from University of Maryland Shock Trauma Center.
- PR (Partial Reinforcement) (Type: PLACEBO_COMPARATOR): Participants in this group will receive NSAIDs, Oxycodone (5mg), and placebo pills to reach a 50% reduction of the total intake of opioids.
- C (Control) (Type: PLACEBO_COMPARATOR): Participants in this group will receive NSAIDs and placebo pills

Based on this trial design, predict the completion outcome and termination type (if applicable).